Eurofins announced today that it received FDA emergency use authorization (EUA) for its at-home COVID-19 testing kit for children three years of age and older.
Luxembourg-based Eurofins’ Clinical Enterprise subsidiary became the first to receive EUA for an at-home nasal PCR test for young children with the empowerDX kit, according to a news release. In March, Eurofins launched the direct-to-consumer, FDA-authorized at-home COVID-19 test kit for consumers 18 years of age and older.
The test kit is available through Eurofins’ Clinical Enterprise/empowerDX subsidiary and can be ordered online for $99, while kits are also available for purchase on Amazon, at RiteAid and through Uber’s on-demand delivery service.
Eurofins’ kit includes step-by-step instructions for the user, a shallow nasal swab, a test tube and a pre-paid FedEx package for the simple return of samples, for which customers will receive results through a secure patient portal within 48 hours.